Literature DB >> 14646343

Granzyme B-induced cell death.

Felipe Andrade1, Livia A Casciola-Rosen, Antony Rosen.   

Abstract

Granzyme B (GrB) is a serine protease that is released by cytotoxic lymphocytes to kill virus-infected and tumor cells. Recent advances in the understanding of GrB have stressed the importance of reassessing the mechanisms by which GrB accomplishes its death functions. These include the uptake and trafficking of GrB within target cells, pathways used to trigger cell death, and the mechanism(s) controlling its killing activity. In addition, the role that GrB plays in human pathologies is still to be defined. The purpose of this review is to discuss recent insights into the biology of GrB and to evaluate its functional significance in health and disease. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14646343     DOI: 10.1159/000074484

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  9 in total

Review 1.  Autoantigens in systemic autoimmunity: critical partner in pathogenesis.

Authors:  A Rosen; L Casciola-Rosen
Journal:  J Intern Med       Date:  2009-06       Impact factor: 8.989

Review 2.  Viral subversion of apoptotic enzymes: escape from death row.

Authors:  Sonja M Best
Journal:  Annu Rev Microbiol       Date:  2008       Impact factor: 15.500

3.  Granzyme B: evidence for a role in the origin of myasthenia gravis.

Authors:  L Casciola-Rosen; A Miagkov; K Nagaraju; F Askin; L Jacobson; A Rosen; D B Drachman
Journal:  J Neuroimmunol       Date:  2008-08-03       Impact factor: 3.478

4.  Detection of apoptosis-specific autoantibodies directed against granzyme B-induced cleavage fragments of the SS-B (La) autoantigen in sera from patients with primary Sjögren's syndrome.

Authors:  M Huang; H Ida; M Kamachi; N Iwanaga; Y Izumi; F Tanaka; K Aratake; K Arima; M Tamai; A Hida; H Nakamura; T Origuchi; A Kawakami; N Ogawa; S Sugai; P J Utz; K Eguchi
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

5.  Granzyme H destroys the function of critical adenoviral proteins required for viral DNA replication and granzyme B inhibition.

Authors:  Felipe Andrade; Edward Fellows; Dieter E Jenne; Antony Rosen; C S H Young
Journal:  EMBO J       Date:  2007-03-15       Impact factor: 11.598

6.  Effects of mdig on proliferation and apoptosis of lung cancer cells.

Authors:  Xiaohui Xu; Lei Cao; Ye Zhang; Hongjian Lian; Zhiwei Sun; Yushang Cui
Journal:  Oncol Lett       Date:  2018-09-28       Impact factor: 2.967

7.  Development of a human immuno-oncology therapeutic agent targeting HER2: targeted delivery of granzyme B.

Authors:  Lawrence H Cheung; Yunli Zhao; Ana Alvarez-Cienfuegos; Khalid A Mohamedali; Yu J Cao; Walter N Hittelman; Michael G Rosenblum
Journal:  J Exp Clin Cancer Res       Date:  2019-07-30

8.  Efficacy of an adapted granzyme B-based anti-CD30 cytolytic fusion protein against PI-9-positive classical Hodgkin lymphoma cells in a murine model.

Authors:  S Schiffer; H P Hansen; G Hehmann-Titt; M Huhn; R Fischer; S Barth; T Thepen
Journal:  Blood Cancer J       Date:  2013-03-22       Impact factor: 11.037

9.  An integrated classifier improves prognostic accuracy in non-metastatic gastric cancer.

Authors:  Xiaofang Xing; Shuqin Jia; Yuxin Leng; Qian Wang; Zhongwu Li; Bin Dong; Ting Guo; Xiaojing Cheng; Hong Du; Ying Hu; Qin Feng; Shenyi Lian; Fengming Luan; Xiaoxiao Ma; Zhe Li; Ming Ni; Ziyu Li; Jiafu Ji
Journal:  Oncoimmunology       Date:  2020-08-30       Impact factor: 8.110

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.